Lundbeck
HLUN-B.CO
#2858
Rank
NZ$7.28 B
Marketcap
$7.58
Share price
0.54%
Change (1 day)
-4.47%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.58

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.59. In 2022 the company made an earnings per share (EPS) of $0.45 a decrease over its 2021 EPS that were of $1.02.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5828.55%
2022$0.45-55.47%
2021$1.02-51.83%
2020$2.11-28.01%
2019$2.93-44.08%
2018$5.2451.94%
2017$3.45126.64%
2016$1.52-120.84%
2015-$7.305622.18%
2014-$0.13-110.03%
2013$1.27-28.08%
2012$1.77-52.1%
2011$3.69-1.31%
2010$3.7415.61%
2009$3.23